These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8333929)

  • 21. [Prevention of preterm birth complications by antenatal corticosteroid administration].
    Schmitz T
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1399-1417. PubMed ID: 27776846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
    Kinalski M; Sledziewski A; Kretowski A
    Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades?
    Mugford M
    Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of antenatal corticosteroids and surfactant replacement on neonatal respiratory distress syndrome.
    Heljić S; Maksić H; Kalkan I; Krdalić B
    Bosn J Basic Med Sci; 2009 Aug; 9(3):225-8. PubMed ID: 19754478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of surfactant administration in neonates with respiratory distress syndrome. III. The role of intra-uterine stimulation on lung maturity].
    Gadzinowski J; Halliday H; Szymankiewicz M; Breborowicz G; Sackey S; Sobczak E
    Ginekol Pol; 1993 Feb; 64(2):74-7. PubMed ID: 8359730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
    Grgić O; Matijević R
    Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antenatal corticosteroids in twin neonates with late preterm birth (ACTWIN [Antenatal Corticosteroids in TWIN late preterm neonates] trial): study protocol for a randomized controlled trial.
    Hong S; Lee SM; Kwak DW; Lee J; Kim SY; Oh JW; Oh S; Park CW; Park JS; Chung JH; Jun JK
    BMC Pregnancy Childbirth; 2019 Apr; 19(1):114. PubMed ID: 30943910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of antenatal corticosteroids according to maternal and perinatal factors: a retrospective cohort study.
    Claire L; Vieux R
    Am J Perinatol; 2015 Sep; 32(11):1070-7. PubMed ID: 25825960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant in the perinatal period.
    Jobe AH
    Early Hum Dev; 1992; 29(1-3):57-62. PubMed ID: 1396280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of antenatal steroids exposure and its effects on neonates.
    Lau HCQ; Tung JSZ; Wong TTC; Tan PL; Tagore S
    Arch Gynecol Obstet; 2017 Dec; 296(6):1091-1096. PubMed ID: 28948354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
    Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial.
    Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.
    Farrell EE; Silver RK; Kimberlin LV; Wolf ES; Dusik JM
    Am J Obstet Gynecol; 1989 Sep; 161(3):628-33. PubMed ID: 2675599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.
    Chun J; Sung SI; Ho YH; Kim J; Park GY; Yoon SA; Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2017 Aug; 32(8):1288-1294. PubMed ID: 28665065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current perspectives on the drug treatment of neonatal respiratory distress syndrome.
    Sweet DG; Halliday HL
    Paediatr Drugs; 1999; 1(1):19-30. PubMed ID: 10937476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.